298 related articles for article (PubMed ID: 34833868)
21. Nano-based drug delivery system for therapeutics: a comprehensive review.
Prakash S
Biomed Phys Eng Express; 2023 Aug; 9(5):. PubMed ID: 37549657
[TBL] [Abstract][Full Text] [Related]
22. Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy.
Wang S; Wang R; Meng N; Guo H; Wu S; Wang X; Li J; Wang H; Jiang K; Xie C; Liu Y; Wang H; Lu W
J Control Release; 2020 Dec; 328():78-86. PubMed ID: 32853731
[TBL] [Abstract][Full Text] [Related]
23. Nano delivery system for paclitaxel: Recent advances in cancer theranostics.
Ying N; Liu S; Zhang M; Cheng J; Luo L; Jiang J; Shi G; Wu S; Ji J; Su H; Pan H; Zeng D
Colloids Surf B Biointerfaces; 2023 Aug; 228():113419. PubMed ID: 37393700
[TBL] [Abstract][Full Text] [Related]
24. An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy.
Uesugi Y; Kawata H; Jo J; Saito Y; Tabata Y
J Control Release; 2010 Oct; 147(2):269-77. PubMed ID: 20696194
[TBL] [Abstract][Full Text] [Related]
25. Relevance of changes in blood fibrinolytic and coagulation parameters during thrombolytic therapy.
Marder VJ
Am J Med; 1987 Aug; 83(2A):15-9. PubMed ID: 3115098
[TBL] [Abstract][Full Text] [Related]
26. Progress of nanomaterials in the treatment of thrombus.
Shen Y; Yu Y; Zhang X; Hu B; Wang N
Drug Deliv Transl Res; 2024 May; 14(5):1154-1172. PubMed ID: 38006448
[TBL] [Abstract][Full Text] [Related]
27. Smart Targeted Delivery Systems for Enhancing Antitumor Therapy of Active Ingredients in Traditional Chinese Medicine.
Kang C; Wang J; Li R; Gong J; Wang K; Wang Y; Wang Z; He R; Li F
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630208
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of thrombosis and research progress on targeted antithrombotic drugs.
Zhang L; Li Z; Ye X; Chen Z; Chen ZS
Drug Discov Today; 2021 Oct; 26(10):2282-2302. PubMed ID: 33895314
[TBL] [Abstract][Full Text] [Related]
29. Urokinase-Conjugated Magnetite Nanoparticles as a Promising Drug Delivery System for Targeted Thrombolysis: Synthesis and Preclinical Evaluation.
Prilepskii AY; Fakhardo AF; Drozdov AS; Vinogradov VV; Dudanov IP; Shtil AA; Bel'tyukov PP; Shibeko AM; Koltsova EM; Nechipurenko DY; Vinogradov VV
ACS Appl Mater Interfaces; 2018 Oct; 10(43):36764-36775. PubMed ID: 30299938
[TBL] [Abstract][Full Text] [Related]
30. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
[TBL] [Abstract][Full Text] [Related]
31. An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy.
Huang Y; Yu L; Ren J; Gu B; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
J Control Release; 2019 Apr; 300():1-12. PubMed ID: 30807804
[TBL] [Abstract][Full Text] [Related]
32. Development and characterization of highly selective target-sensitive liposomes for the delivery of streptokinase: in vitro/in vivo studies.
Vaidya B; Nayak MK; Dash D; Agrawal GP; Vyas SP
Drug Deliv; 2016; 23(3):801-7. PubMed ID: 24865294
[TBL] [Abstract][Full Text] [Related]
33. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.
Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z
ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticles incorporated in nanofibers using electrospinning: A novel nano-in-nano delivery system.
Shetty K; Bhandari A; Yadav KS
J Control Release; 2022 Oct; 350():421-434. PubMed ID: 36002053
[TBL] [Abstract][Full Text] [Related]
35. Medicine. Leveraging shear stress to bust clots with nanoparticles.
Lavik E; Ustin J
Science; 2012 Aug; 337(6095):658-9. PubMed ID: 22879494
[No Abstract] [Full Text] [Related]
36. Streptokinase entrapment in interdigitation-fusion liposomes improves thrombolysis in an experimental rabbit model.
Perkins WR; Vaughan DE; Plavin SR; Daley WL; Rauch J; Lee L; Janoff AS
Thromb Haemost; 1997 Jun; 77(6):1174-8. PubMed ID: 9241753
[TBL] [Abstract][Full Text] [Related]
37. Targeted thrombolysis by using c-RGD-modified N,N,N-Trimethyl Chitosan nanoparticles loaded with lumbrokinase.
Liao J; Ren X; Yang B; Li H; Zhang Y; Yin Z
Drug Dev Ind Pharm; 2019 Jan; 45(1):88-95. PubMed ID: 30198790
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review.
Zhou L; Li Y; Liang Q; Liu J; Liu Y
J Drug Target; 2022 Jul; 30(6):577-588. PubMed ID: 35179094
[TBL] [Abstract][Full Text] [Related]
39. Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy.
Guan Q; Dou H
Front Physiol; 2021; 12():763085. PubMed ID: 34916956
[TBL] [Abstract][Full Text] [Related]
40. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound.
Kawata H; Uesugi Y; Soeda T; Takemoto Y; Sung JH; Umaki K; Kato K; Ogiwara K; Nogami K; Ishigami K; Horii M; Uemura S; Shima M; Tabata Y; Saito Y
J Am Coll Cardiol; 2012 Dec; 60(24):2550-7. PubMed ID: 23158532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
